Dermatology
From the Journals
Analysis of PsA guidelines reveals much room for improvement on conflicts of interest
Researchers show that a majority of the authors of the most recent psoriatic arthritis clinical practice guidelines from the American College of...
Latest News
52-week data show lebrikizumab atopic dermatitis effects maintained
ADvocate1 and ADvocate2 are two of several phase 3 trials evaluating the efficacy and safety of lebrikizumab for the treatment of atopic...
Latest News
Ruxolitinib repigments many vitiligo-affected body areas
Ruxolitinib is a Janus kinase 1/2 inhibitor that has been available for the treatment for atopic dermatitis for more than a year.
Latest News
How to handle pesky molluscum contagiosum lesions
“If you don’t treat them, they’re going to spread,” Dr. Rebecca Smith said.
Feature
Breakthrough COVID studies lend support to use of new boosters in immunosuppressed patients
The findings of two studies underscore the importance of booster vaccine doses in those with immune-mediated inflammatory diseases who are taking...
From the Journals
What’s the true role of Demodex mites in the development of papulopustular rosacea?
“Growing knowledge of rosacea’s pathophysiology has established that a consistent multivariate disease process underlies its potential...
Latest News
Monkeypox features include mucocutaneous involvement in almost all cases
In Europe, the data support monkeypox as a largely sexually transmitted disease that self-resolves in about 4 weeks.
Latest News
Alopecia areata: Positive results reported for two investigational JAK inhibitors
“This is truly transformative therapy,” one of the investigators, Brett King, MD, PhD, said.
Latest News
Training program linked to less hand eczema for hairdressers
“The lack of primary prevention of OHE in hairdressing vocational schools may be a missed opportunity in the prevention of the disease.”
News from the FDA/CDC
FDA approves dupilumab for treatment of prurigo nodularis
Approval was based on data from two randomized, controlled trials, PRIME and PRIME2, comparing dupilumab with placebo in 311 adults with...
Latest News
Many factors linked with higher, lower risk for hand eczema
Hand eczema is one of the most common skin disorders and is the most common occupational skin disease, the authors wrote.